English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 感染症 > 米国における感染症診断市場
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

米国における感染症診断市場

U.S. Infectious Disease Diagnostics Markets

発行 Frost & Sullivan
出版日 2006年04月 商品コード 38052
ページ情報 英文  
価格
US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License)
US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

Market Overview

The U.S. infectious disease diagnostics market will play a significant role in the dynamic IVD market. This market is segmented according to molecular, immunoassays, and culture infectious disease products. Total market revenues for base year 2005 are $3,823.1 with a CAGR of 7.7%. The most substantial growth is expected in the molecular segment. The U.S. infectious disease diagnostics market is highly competitive and saturated

Tremendous growth opportunities exist in the U.S. infectious disease in-vitro diagnostics market. High growth areas include viral load testing, nosocomial infection screening, rapid influenza detection, and STD testing.

Rapid detection and fast turn-around time (TAT) are able to lower total overall healthcare costs. Quick TAT is especially relevant to infectious disease testing, as fast diagnosis increases treatment options and patient prognosis.

Technical superiority of molecular methods is phasing out other types or more traditional methods, such as culture based tests, which have TATs of only days and are labor intensive.

Table of Contents

  • 1. Executive Summary
    • 1. Executive Summary
      • 1. Executive Summary
  • 2. Total Infectious Disease Diagnostics Market
    • 1. Market Overview
      • 1. Introduction
      • 2. Research Methodology
      • 3. Market Engineering Analysis
    • 2. Market Forecasts and Market Share Analysis
      • 1. Scope and Segmentation
      • 2. Market and Technology Trends
      • 3. Market Forecasts
      • 4. Market Share Analysis
    • 3. Market Challenges and Strategic Recommendations
      • 1. Industry Challenges
      • 2. Strategic Recommendations
  • 3. Molecular Infectious Disease Diagnostics Market
    • 1. Market Overview and Forecasts
      • 1. Introduction
      • 2. Market Engineering Measurements
      • 3. Revenue Forecast
    • 2. Market Drivers and Restraints
      • 1. Market Drivers
      • 2. Market Restraints
    • 3. Competitive Analysis
      • 1. Competitive Structure
      • 2. Market Share Analysis
      • 3. Product Analysis
  • 4. Immunoassay Infectious Disease Diagnostics Market
    • 1. Market Overview and Forecasts
      • 1. Introduction
      • 2. Market Engineering Measurements
      • 3. Revenue Forecast
    • 2. Market Drivers and Restraints
      • 1. Market Drivers
      • 2. Market Restraints
    • 3. Competitive Analysis
      • 1. Competitive Structure
      • 2. Market Share Analysis
      • 3. Product Analysis
  • 5. Culture Infectious Disease Diagnostics Market
    • 1. Market Overview and Forecasts
      • 1. Introduction
      • 2. Market Engineering Measurements
      • 3. Revenue Forecast
    • 2. Market Drivers and Restraints
      • 1. Market Drivers
      • 2. Market Restraints
    • 3. Competitive Analysis
      • 1. Competitive Structure and Market Share Analysis
      • 2. Product Analysis
  • 6. Appendix
    • 1. Decision Support Database
      • 1. Global Incidence of TB
      • 2. Global Reported AIDS Cases
      • 3. Global AIDS Mortality Rates
      • 4. Global Incidence of Haemophilus Type B
      • 5. Global Incidence of Hepatitis A
      • 6. Global Incidence of Hepatitis B
      • 7. Global HIV Prevalence
      • 8. Global Incidence of Malaria
      • 9. Global Cases of Rubella
      • 10. Global Incidence of Syphilis
      • 11. U.S. Initial Physician Visit for Genital Herpes
      • 12. U.S. Incidence of Haemophilus Influenzae
      • 13. U.S. Cases of Chlamydia
      • 14. U.S. Cases of Gonorrhea
      • 15. U.S. Cases of West Nile Virus

.

Back to Top